Tradestie Institutional Equity Comparison Engine
MESO vs MGNX โ Head-to-Head Terminal
6-dimension institutional benchmarking across valuation, multi-year operating margins, normalized momentum, and dealer gamma corridors.
Pillar 1 Executive Scorecard & Category Winner Tally
MGNX Overall Edge
MGNX Captures Institutional Edge (4โ0 Pillars ยท 6โ4 Matrix Metrics)
Tradestie Institutional Equity Comparison Engine assigns the overall head-to-head edge to MacroGenics, Inc. (MGNX) driven by superior Valuation, Growth & Margin, Momentum & Technical, Options & Structure. Fundamentally, MESO trades at N/M Forward P/E with -42.6% operating margin (+390.7% YoY revenue) versus MGNX at 61.0x Forward P/E and -21.7% operating margin (+378.0% YoY). In options structure, MESO sits in UNCLASSIFIED (37th %ile IV; Dealer Gamma Walls on Pro) against MGNX sits in BREAKDOWN (1st %ile IV; Dealer Gamma Walls on Pro).
Valuation Winner
MGNX
MESO N/M vs MGNX 61.0x Fwd P/E
Growth & Margin Winner
MGNX
Op Margin -42.6% vs -21.7% ยท YoY +390.7% vs +378.0%
Momentum & Technical Winner
MGNX
1Y -16.4% vs +26.6% ยท 52W Pos 6% vs 19%
Options & Structure Winner
MGNX
UNCLASSIFIED (37th %ile IV) vs BREAKDOWN (1st %ile IV)
MESO
NASDAQ
Mesoblast Limited American Depositary Shares
Biological Products, (No Diagnostic Substances)
$12.47
-6.03% 1D
Market Cap
$1.7B
1M Return
-6.1%
1Y Return
-16.42%
Forward P/E
N/M
Unified AI Score
34.6 / 100
SELL
Tech 25.0
Fund 40.0
Flow 50.0
Mom 50.0
MGNX
NASDAQ
MacroGenics, Inc.
Pharmaceutical Preparations
$2.02
-7.95% 1D
Market Cap
$145.9M
1M Return
-37.69%
1Y Return
+26.56%
Forward P/E
61.0x
Unified AI Score
49.4 / 100
HOLD
Tech 25.0
Fund 47.0
Flow 65.0
Mom 55.0
Pillar 2 Normalized Relative Return Performance (% Indexed to 0%)
1Y Indexed Return:
MESO -16.42%
MGNX +26.56%
Spread: +42.98 pp (MGNX Lead)
Pillar 3 Operating Profitability Benchmark (Trailing 12-Month)
MESO TTM Op. Margin: -42.6%
MGNX TTM Op. Margin: -21.7%
Standardized multi-year USD domestic revenue schedules are unavailable for foreign-domiciled ADR filing schedules on MESO vs MGNX. Trailing 12-month operating profitability (MESO -42.6% vs MGNX -21.7%) and valuation multiples (MESO N/M vs MGNX 61.0x Forward P/E) are benchmarked directly in Pillar 4 below.
Pillar 4 Head-to-Head Fundamental & Valuation Matrix
| Institutional Metric | MESO | MGNX | Criterion | Row Winner |
|---|---|---|---|---|
| Market Capitalization Scale | $1.7B | $145.9M | Larger Scale | MESO |
| Trailing P/E Ratio Valuation | N/M | 61.0x | Lower Multiple | MGNX |
| Forward P/E Ratio Valuation | N/M | 61.0x | Lower Multiple | MGNX |
| Revenue Growth (YoY) Growth | +390.7% | +378.0% | Higher Growth | MESO |
| Operating Margin (TTM) Profitability | -42.6% | -21.7% | Higher Margin | MGNX |
| Net Profit Margin Profitability | -47.8% | -8.3% | Higher Margin | MGNX |
| Return on Equity (ROE) Capital Efficiency | -9.9% | -225.9% | Higher ROE | MESO |
| 52-Week Range Position Momentum | 6% ($12โ$22) | 19% ($1โ$5) | Stronger Trend | MGNX |
| Beta / 30D Volatility Risk Regime | 1.18ฮฒ ยท 78% Vol | 1.37ฮฒ ยท 148% Vol | Lower Realized Risk | MESO |
| Unified Institutional Score Composite Signal | 34.6 / 100 (SELL) | 49.4 / 100 (HOLD) | Higher Composite | MGNX |
Pillar 5 Options Structure, IV Regime & Dealer Gamma Corridor
Full MESO vs MGNX Buy Guide
MESO
UNCLASSIFIED
0d in phase ยท OBV NEUTRAL
Put Wall Floor
Pro Only
Call Wall Magnet
Pro Only
IV Percentile
37th %ile
IV Regime
Balanced (25thโ60th %ile)
MGNX
BREAKDOWN
122d in phase ยท OBV NEUTRAL
Put Wall Floor
Pro Only
Call Wall Magnet
Pro Only
IV Percentile
1st %ile
IV Regime
Compressed (<25th %ile)
Pillar 6 90-Day Technical & R&D Innovation Disclosures
Corporate R&D & Foundry Tracker
Neither MESO nor MGNX registered frontier semiconductor/AI engineering publications in the trailing 90-day window; head-to-head edge is anchored on operating margin trajectory, valuation multiples, and options structure above.